During the first half of 2019, over 2,000 new drug applications were made to the U.S. Food and Drug Administration by India's top five pharma companies. From the total applications, 1,374 applications were approved. Overall, India had some of the highest approval ratings from the U.S. FDA in terms of new drug applications.
Number of Indian ANDAs approved by the U.S. FDA from first half of 2017 to first half of 2019
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Rate of approval for Indian pharma ANDA by U.S. FDA 2017-2019
- Premium Statistic R&D investments as part of sales by leading Indian pharma companies in FY 2012-2021
- Premium Statistic Value of Indian drugs and pharmaceutical exports FY 2017-2019
- Premium Statistic Net sales of Indian pharma companies in 2017-2019
- Premium Statistic Operating margin in Indian pharma companies in 2017-2019
- Premium Statistic Net profit margin of Indian pharma industry in 2017-2019
- Premium Statistic Pharmaceutical industry: top EU import partners 2010-2022
- Basic Statistic Medicine spending in emerging pharmaceutical markets 2026
- Premium Statistic Pharmaceutical industry: EU trade partners in exports 2010-2022
- Premium Statistic Enterprises in pharmaceuticals manufacturing in the UK 2008-2021, by subdivision
About the region
10
- Premium Statistic Drugs and pharmaceutical export value India FY 2023, by leading destination
- Premium Statistic Value of drugs and pharma imports from China to India 2019, by segment
- Premium Statistic Fish and fishery product exports value from India FY 2023, by leading destination
- Premium Statistic Net profit of major pharma companies India 2024
- Basic Statistic Value of forest product imports into India 2017, by country
- Basic Statistic Value of log imports into India 2017, by country
- Basic Statistic Value of wood product imports into India 2017, by country
- Premium Statistic Patented drugs revenue in prescribed drug market in India 2008-2015
- Premium Statistic Indian tea exports volume FY 2023, by destination country
- Premium Statistic Indian tea exports value FY 2023, by destination country
Selected statistics
9
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
Other regions
10
- Basic Statistic Number of approved ANDAs in U.S. FY 2009-2023
- Basic Statistic Net sales of Recipharm 2009-2022
- Basic Statistic Export value of medicinal and pharmaceutical products in Denmark 2010-2023
- Basic Statistic Drug cost distribution by drug type in public drug plans Canada 2021/2022
- Basic Statistic Generic market share volume in community pharmacies in Italy 2012-2022
- Basic Statistic Sales volume pharmaceuticals in Norway by drug category 2022
- Basic Statistic Generic market value share of community pharmacies in Slovakia 2000-2021
- Premium Statistic Parapharmaceuticals sales in Russia 2019-2020, by product
- Premium Statistic Generic market share of community and hospital pharmacies in Finland 2007-2017
- Basic Statistic Market share of generics in European countries 2021
Related statistics
10
- Basic Statistic Medicine and pharmaceutical product import value India FY 1961-2023
- Premium Statistic Lupin's net sales FY 2015-2022
- Premium Statistic Sun Pharma's income FY 2010-2023
- Premium Statistic Sun Pharma's profit after tax FY 2014-2023
- Premium Statistic Dr. Reddy's Laboratories' cash flow FY 2018-2023, by type
- Premium Statistic Aurobindo Pharma's net debt to EBITDA ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's net debt to equity ratio FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA FY 2013-2023
- Premium Statistic Aurobindo Pharma's revenue from U.S. formulations FY 2013-2023
- Premium Statistic Aurobindo Pharma's EBITDA margin FY 2013-2023
Further related statistics
10
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- GSK's operating profit by division 2006-2021
- Celgene's revenue and net income 2006-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Medicinal market growth worldwide including rebates 2009-2018
Further Content: You might find this interesting as well
Statistics
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- GSK's operating profit by division 2006-2021
- Celgene's revenue and net income 2006-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Medicinal market growth worldwide including rebates 2009-2018
CARE Ratings. (December 26, 2018). Number of Indian ANDAs approved by the U.S. FDA from first half of 2017 to first half of 2019 [Graph]. In Statista. Retrieved April 25, 2024, from https://www.statista.com/statistics/999240/india-anda-approvals-by-usfda/
CARE Ratings. "Number of Indian ANDAs approved by the U.S. FDA from first half of 2017 to first half of 2019." Chart. December 26, 2018. Statista. Accessed April 25, 2024. https://www.statista.com/statistics/999240/india-anda-approvals-by-usfda/
CARE Ratings. (2018). Number of Indian ANDAs approved by the U.S. FDA from first half of 2017 to first half of 2019. Statista. Statista Inc.. Accessed: April 25, 2024. https://www.statista.com/statistics/999240/india-anda-approvals-by-usfda/
CARE Ratings. "Number of Indian Andas Approved by The U.S. Fda from First Half of 2017 to First Half of 2019." Statista, Statista Inc., 26 Dec 2018, https://www.statista.com/statistics/999240/india-anda-approvals-by-usfda/
CARE Ratings, Number of Indian ANDAs approved by the U.S. FDA from first half of 2017 to first half of 2019 Statista, https://www.statista.com/statistics/999240/india-anda-approvals-by-usfda/ (last visited April 25, 2024)
Number of Indian ANDAs approved by the U.S. FDA from first half of 2017 to first half of 2019 [Graph], CARE Ratings, December 26, 2018. [Online]. Available: https://www.statista.com/statistics/999240/india-anda-approvals-by-usfda/